Fabian Müller

5.1k total citations · 2 hit papers
50 papers, 667 citations indexed

About

Fabian Müller is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Fabian Müller has authored 50 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 22 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Fabian Müller's work include CAR-T cell therapy research (22 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and B-cell Immunology (6 papers). Fabian Müller is often cited by papers focused on CAR-T cell therapy research (22 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and T-cell and B-cell Immunology (6 papers). Fabian Müller collaborates with scholars based in Germany, United States and Switzerland. Fabian Müller's co-authors include Andréas Mackensen, Georg Schett, Gerald Illerhaus, Jule Taubmann, Simon Völkl, Michael Aigner, Friedrich Feuerhake, Jürgen Finke, Martina Deckert and Jason J. LeBlanc and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Fabian Müller

45 papers receiving 656 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advancements and challenges in CAR T cell therapy in autoimmune diseases

2024 85 citations Georg Schett, Fabian Müller et al. Nature Reviews Rheumatology profile →
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells

2025 15 citations Fabian Müller, Andreas Wirsching et al. Nature Medicine profile →

Peers

Countries citing papers authored by Fabian Müller

Since Specialization

Citations

This map shows the geographic impact of Fabian Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabian Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabian Müller more than expected).

Fields of papers citing papers by Fabian Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabian Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabian Müller. The network helps show where Fabian Müller may publish in the future.

Co-authorship network of co-authors of Fabian Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Fabian Müller. A scholar is included among the top collaborators of Fabian Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabian Müller. Fabian Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells breakdown → 2025 ·Nature Medicine ·Fabian Müller, Andreas Wirsching, Melanie Hagen, Simon Völkl, Carlo Tur, Maria Gabriella Raimondo, Jule Taubmann, Laura Bucci, (unknown), Sascha Kretschmann, Michael Aigner, Markus Eckstein, (unknown), Soraya Kharboutli, Sebastian Boeltz, Armin Atzinger, (unknown), Georg Schett, Andréas Mackensen, Ricardo Grieshaber‐Bouyer	15
2	611O Updated results from BNT211-01 (NCT04503278), an ongoing, first-in-human, phase I study evaluating safety and efficacy of CLDN6 CAR T cells and a CLDN6-encoding mRNA vaccine in patients with relapsed/refractory CLDN6+ solid tumors 2024 ·Annals of Oncology ·(unknown), Andréas Mackensen, (unknown), Winfried Alsdorf, (unknown), Daniel Heudobler, (unknown), Antonia Busse, Stephan Mielke, Sander Bins, Guy Ungerechts, Carsten Bokemeyer, Sebastian Klobuch, Nadine Kutsch, Fabian Müller, (unknown), Zhong Wei, (unknown), (unknown), Uğur Şahin	7
3	The development of children’s and adults’ use of kinematic cues for visual anticipation and verbal prediction of action 2024 ·Journal of Experimental Child Psychology ·(unknown), Nicole Altvater‐Mackensen, (unknown), Fabian Müller, (unknown), Petra Hauf, Markus Paulus	0
4	Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality 2024 ·Blood Advances ·Kai Rejeski, Yucai Wang, Doris K. Hansen, Gloria Iacoboni, Emmanuel Bachy, Radhika Bansal, Olaf Penack, Fabian Müller, Wolfgang Bethge, Javier Muñoz, Razan Mohty, Veit Bücklein, Pere Barba, Frederick L. Locke, (unknown), Michael D. Jain, Marion Subklewe	29
5	Selective CAR T cell–mediated B cell depletion suppresses IFN signature in SLE 2024 ·JCI Insight ·Artur Wilhelm, David Chambers, Fabian Müller, Aline Bözec, Ricardo Grieshaber‐Bouyer, Thomas Winkler, (unknown), Andréas Mackensen, Georg Schett, Gerhard Krönke	24
6	Advancements and challenges in CAR T cell therapy in autoimmune diseases breakdown → 2024 ·Nature Reviews Rheumatology ·Georg Schett, Fabian Müller, Jule Taubmann, Andréas Mackensen, Wei Wang, R. Furie, Ralf Gold, Aiden Haghikia, (unknown), Roberto Caricchio, Maria Antonietta D’Agostino, Franco Locatelli, Carl H. June, Dimitrios Mougiakakos	85
7	Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response 2023 ·Cell Death and Disease ·(unknown), (unknown), (unknown), Scott Parker, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Markus Metzler, Andréas Mackensen, Vidyalakshmi Chandramohan, Fabian Müller	5
8	Identification of a second glycoform of the clinically prevalent O1 antigen from Klebsiella pneumoniae 2023 ·Proceedings of the National Academy of Sciences ·Steven D. Kelly, Olga G. Ovchinnikova, Fabian Müller, (unknown), Martin Braun, (unknown), Michael Kowarik, Rainer Follador, Todd L. Lowary, (unknown), Chris Whitfield	11
9	OP0141 LONG TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS - DATA FROM THE FIRST SEVEN PATIENTS 2023 ·Annals of the Rheumatic Diseases ·(unknown), Fabian Müller, Sebastian Boeltz, Simon Völkl, Michael Aigner, (unknown), (unknown), Franco Locatelli, Maria Antonietta D’Agostino, Regina Gary, (unknown), Soraya Kharboutli, Dimitrios Mougiakakos, Gerhard Krönke, (unknown), Georg Schett	11
10	LBA35 BNT211-01: Interim results from a repeat dose escalation study of CLDN6 CAR-T cells manufactured with an automated process ± a CLDN6-encoding CAR-T cell-amplifying RNA Vaccine (CARVac) 2023 ·Annals of Oncology ·Andréas Mackensen, (unknown), Winfried Alsdorf, Christian Koenecke, (unknown), Peter Borchmann, Daniel Heudobler, Andreas Busse, Sebastian Klobuch, Nadine Kutsch, Fabian Müller, Carsten Bokemeyer, (unknown), (unknown), (unknown), (unknown), (unknown), Benjamin Rengstl, Özlem Türeci, Uğur Şahin	1
11	Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy 2023 ·Molecular Therapy — Methods & Clinical Development ·(unknown), (unknown), (unknown), (unknown), (unknown), Fabian Müller, Michael Aigner, Simon Völkl, Andréas Mackensen, Georg Schett, Samik Basu	28
12	POS1238 FIRST EVIDENCE FOR EFFICACY OF CAR-T CELL TREATMENT IN REFRACTORY ANTISYNTHETASE SYNDROME 2023 ·Annals of the Rheumatic Diseases ·(unknown), Fabian Müller, Sebastian Boeltz, Johannes Knitza, Simon Völkl, Michael Aigner, Arnd Kleyer, (unknown), Franco Locatelli, Maria Antonietta D’Agostino, (unknown), (unknown), Soraya Kharboutli, (unknown), Gerhard Krönke, (unknown), Georg Schett	2
13	A biosynthetic route for polysialylating proteins in Escherichia coli 2017 ·Metabolic Engineering ·Timothy G. Keys, Michael Wetter, (unknown), (unknown), Simona Russo, Manuela Mally, (unknown), (unknown), Fabian Müller, Jörg Schneider, Amirreza Faridmoayer, Chia‐Wei Lin, Markus Aebi	31
14	Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design 2016 ·Clinical Cancer Research ·Fabian Müller, (unknown), Xiu Fen Liu, Alan S. Wayne, Ira Pastan	7
15	Protein Kinase Inhibitor H89 Enhances the Activity of Pseudomonas Exotoxin A–Based Immunotoxins 2016 ·Molecular Cancer Therapeutics ·Xiufen Liu, Fabian Müller, Alan S. Wayne, Ira Pastan	10
16	Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line 2015 ·PLoS ONE ·Kevin Hollevoet, (unknown), Fabian Müller, Ira Pastan	10
17	Anti‐tumor activity of a B‐cell receptor‐targeted peptide in a novel disseminated lymphoma xenograft model 2011 ·International Journal of Cancer ·Claudia Wehr, Fabian Müller, Julia Schüler, (unknown), (unknown), Henning Seismann, Edzard Spillner, (unknown), Tanja Schneider‐Merck, Mascha Binder, Heinz‐Herbert Fiebig, Roland Mertelsmann, Martin Trepel	3
18	High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study 2008 ·Annals of Oncology ·Gerald Illerhaus, Reinhard Marks, Fabian Müller, Gabriele Ihorst, Friedrich Feuerhake, Martina Deckert, Jason J. LeBlanc, Jürgen Finke	95
19	Identification of Their Epitope Reveals the Structural Basis for the Mechanism of Action of the Immunosuppressive Antibodies Basiliximab and Daclizumab 2007 ·Cancer Research ·Mascha Binder, F.‐Nora Vögtle, Stefan Michelfelder, Fabian Müller, Gerald Illerhaus, (unknown), Roland Mertelsmann, Martin Trepel	32
20	[Referral pattern of the heart catheterization laboratory at the Bern Island University Hospital]. 2001 ·PubMed ·Fabian Müller, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact